Moderate intake of myristic acid in sn-2 position has beneficial lipidic effects and enhances DHA of cholesteryl esters in an interventional study.
about
Saturated Fat Consumption and Risk of Coronary Heart Disease and Ischemic Stroke: A Science Update.Saturated fats: a perspective from lactation and milk compositionThe complex and important cellular and metabolic functions of saturated fatty acidsThe influence of a formula supplemented with dairy lipids and plant oils on the erythrocyte membrane omega-3 fatty acid profile in healthy full-term infants: a double-blind randomized controlled trial.Content and Composition of Branched-Chain Fatty Acids in Bovine Milk Are Affected by Lactation Stage and Breed of Dairy Cow.Morphological and reproductive characterization in hyacinth bean, Lablab purpureus (L.) sweet germplasm with clinically proven nutraceutical and pharmaceutical traits for use as a medicinal food.Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions.In rat hepatocytes, myristic acid occurs through lipogenesis, palmitic acid shortening and lauric acid elongation.Substitution of dietary oleic acid for myristic acid increases the tissue storage of α-linolenic acid and the concentration of docosahexaenoic acid in the brain, red blood cells and plasma in the rat.Effects of rapeseed and soybean oil dietary supplementation on bovine fat metabolism, fatty acid composition and cholesterol levels in milk.No effect of adding dairy lipids or long chain polyunsaturated fatty acids on formula tolerance and growth in full term infants: a randomized controlled trial.An infant formula containing dairy lipids increased red blood cell membrane Omega 3 fatty acids in 4 month-old healthy newborns: a randomized controlled trial.Variations in daily intakes of myristic and alpha-linolenic acids in sn-2 position modify lipid profile and red blood cell membrane fluidity.
P2860
Q33810706-AC504D49-CED2-46C0-B78E-25EF8F50F648Q34180212-DF18F16E-BD50-43D1-A91C-1F3A67ACE9B6Q34280533-0A9E81E3-288A-492F-9308-DE96A681C71AQ34448601-033F46B5-0B7D-476D-9565-28B0EDA1E537Q35941423-BDDE13D8-4042-4189-9A8E-CB047D231EDCQ37995663-1AD66CF9-A064-4A47-AFF4-070F0CEF6929Q40966013-38E6AD29-0F2A-4913-9845-D70D8D85496FQ42719910-0F16DA56-0014-4D13-A9F5-EDC536B4E9C9Q42720234-803D3EF5-A9CE-4D30-B23D-7C7B8FF71EA1Q48384180-E271F845-90B5-4EC7-9437-811929DC2EB9Q48528228-790F3F17-E664-4742-A4DF-AA2B47EA78C1Q50058061-BA52A640-7C78-4697-B5B1-DA3681C4C280Q50724263-4379F50C-4694-4ECE-80A2-ED6651C5E6FD
P2860
Moderate intake of myristic acid in sn-2 position has beneficial lipidic effects and enhances DHA of cholesteryl esters in an interventional study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Moderate intake of myristic ac ...... rs in an interventional study.
@en
Moderate intake of myristic ac ...... rs in an interventional study.
@nl
type
label
Moderate intake of myristic ac ...... rs in an interventional study.
@en
Moderate intake of myristic ac ...... rs in an interventional study.
@nl
prefLabel
Moderate intake of myristic ac ...... rs in an interventional study.
@en
Moderate intake of myristic ac ...... rs in an interventional study.
@nl
P2093
P1476
Moderate intake of myristic ac ...... rs in an interventional study.
@en
P2093
Evelyne Peuchant
François Mendy
Henry Dabadie
Mireille Bernard
Pascale LeRuyet
P304
P356
10.1016/J.JNUTBIO.2005.01.010
P577
2005-06-01T00:00:00Z